Navigation Links
HMS Holdings Corp. to Present at Bank of America and Merrill Lynch 2009 Healthcare Conference
Date:5/7/2009

NEW YORK, May 7 /PRNewswire-FirstCall/ -- HMS (Nasdaq: HMSY) today announced that it will present at the Bank of America and Merrill Lynch 2009 Healthcare Conference, which will be held Tuesday, May 12 - Thursday, May 14 at The Palace Hotel, New York City.

The Company will present on Tuesday, May 12th at 11:20 a.m. ET.

A live broadcast of the Company's presentation can be accessed through our website at http://www.hms.com/investor_relations/investors_presentations.asp. The presentation will also be available "on demand" approximately one hour after the live presentation and will be available until May 29, 2009.

HMS Holdings Corp. is the nation's leader in cost management, coordination of benefits, and program integrity services for government healthcare programs. HMS serves the Medicaid programs of 40 states, over 90 Medicaid managed care plans, the Centers for Medicare and Medicaid Services (CMS), and Veterans Administration facilities. HMS helps ensure that healthcare claims are paid correctly and by the responsible party. As a result of the company's services, government healthcare programs recover over $1.0 billion annually, and obtain access to data that helps them prevent billions of dollars more in erroneous payments.


'/>"/>
SOURCE HMS Holdings Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. China Pharma Holdings, Inc. to Report First Quarter 2009 Financial Results on May 15, 2009
2. InfuSystem Holdings Reports $9.2 Million of Revenue and 45% Increase in Adjusted EBITDA for the First Quarter of 2009
3. Duane Reade Holdings, Inc. Reports First Quarter 2009 Results
4. HMS Holdings Corp. Announces First Quarter 2009 Financial Results
5. China Pharma Holdings, Inc. Retains Global Investor Communications Team
6. China Pharma Holdings, Inc. Appoints Chief Financial Officer and Board Member
7. JAG Media Holdings, Inc. Announces Update of the Status of its Proposed Acquisition of CardioGenics Inc.
8. Innophos Holdings, Inc. Schedules Call to Discuss First Quarter 2009 Results
9. Zimmer Holdings, Inc. Reports First Quarter 2009 Financial Results
10. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 Second Quarter Earnings Webcast
11. Lincare Holdings Inc. Announces First Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Calibration, qualification, and the appropriate ... and maintaining GMP and USP compliance. In a new webinar from METTLER TOLEDO ... " these requirements are explained. The challenge is to determine how to ...
(Date:3/28/2017)... ... 2017 , ... Neurotechnology , a provider of high-precision ... tracking products: the new NCheck Cloud Bio Attendance cloud-based service and the updated  ... recognition to enable users to check in and out from anywhere via the ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... plans work, the Self-Funding Success website has recently developed and published an informational ... Plans ” was created based on common inquiries the site’s team of third ...
(Date:3/28/2017)... ... March 28, 2017 , ... A ... achieve the “perfect smile.” The National Association of Dental Laboratories (NADL) is informing ... should be aware of when utilizing dental laboratories and technicians that create these ...
(Date:3/28/2017)... ... March 28, 2017 , ... Public relations pros work hard to ... of business channels. , While many results are clear, much of PR is hard ... , When it comes to measurement, firms should always take an all-inclusive approach that ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017  ImMAGE Biotherapeutics (OTCMKTS: ... immunotherapy successfully passed early toxicology and efficacy studies. The ... to target a specific protein, MAGE A, in an ... breast cancer. After 4 weeks of ... to show very little toxicity in a full toxicology ...
(Date:3/27/2017)... 27, 2017  Sanderling Ventures, portfolio company, Torax ... division of Johnson & Johnson. Torax manufactures and markets ... of gastro-esophageal reflux disease (GERD). The LINK device ... and the procedure is currently available in the ... Medical was founded by Sanderling Ventures, Mayo Medical ...
(Date:3/27/2017)... AVIV, Israel , March 27, 2017 ... on oncology and immunology, announced today that AGI-134, an immunotherapy ... announced acquisition of Agalimmune Ltd., will be featured at the ... in Washington, DC to be ... ...
Breaking Medicine Technology: